PTEN and prostate cancer: In one report, the treatment of prostate cancer cell lines with SMCSO did not change mitochondrial or glycolytic function, and neither were there significant changes in reactive oxygen species (ROS) or the redox status of the phosphatase and tensin homolog (PTEN) protein in normal prostate epithelial cells [10].